Home
 Search
 Category
 Compounds
 Status
 Download
 Contacts
 Resources


Compound category: Organic oxygen compounds
(total 26 related compounds in database, current show from 11 to 20)
 
Compound name 2D structure Target pathogen(s) Related VF/VFcategory Max phase Reference(s)
1-N,3-N-dimethyl-5-[4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]benzene-1,3-dicarboxamide Depiction based on curated SMILES H H H H O H HO HO HO OH O NH CH 3 NH O CH 3 O Escherichia Type 1 fimbriae Preclinical (in vitro) Han Z, et al. 2010. J Med Chem
Bio8B6 Depiction based on curated SMILES HO Cl Cl H 3 C N Cl O Escherichia TTSS (Type III secretion system) Preclinical (in vitro) Gauthier A, et al. 2005. Antimicrob Agents Chemother
3-[4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-N-[2-[2-[2-[[3-[4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]benzoyl]amino]ethoxy]ethoxy]ethyl]benzamide Depiction based on curated SMILES OH OH OH OH O H H H H OH OH OH OH O H H H H H O N H O O HN O H O O Escherichia Type 1 fimbriae Preclinical (in vitro) Han Z, et al. 2010. J Med Chem
dimethyl 5-[4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]benzene-1,3-dicarboxylate Depiction based on curated SMILES H H H H O H HO HO HO OH O O CH 3 O O CH 3 O Escherichia Type 1 fimbriae Preclinical (in vitro) Han Z, et al. 2010. J Med Chem
methyl 3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzoate Depiction based on curated SMILES OH OH HO HO H 3 C O O O O Escherichia Type 1 fimbriae Preclinical (in vitro) Cusumano CK, et al. 2011. Sci Transl Med
methyl 3-[4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]benzoate Depiction based on curated SMILES OH OH HO HO H 3 C O O O O Escherichia Type 1 fimbriae Preclinical (in vitro) Cusumano CK, et al. 2011. Sci Transl Med
N-methyl-3-[4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]benzamide Depiction based on curated SMILES OH OH HO HO H 3 C O O O NH Escherichia Type 1 fimbriae Preclinical (in vitro) Cusumano CK, et al. 2011. Sci Transl Med
1-(3,4-dichlorophenyl)-2-[2-imino-3-(2-piperidin-1-ium-1-ylethyl)benzimidazol-1-yl]ethanone Depiction based on curated SMILES Cl Cl O HN N N H + N Mycobacterium Motility Preclinical (in vitro) Ouertatani-Sakouhi H, et al. 2017. PLoS One
3-(3,5-DIBROMO-4-HYDROXY-BENZOYL)-2-ETHYL-BENZOFURAN-6-SULFONIC ACID [4-(THIAZOL-2-YLSULFAMOYL)-PHENYL]-AMIDE Depiction based on curated SMILES O S O O NH N S Br OH Br O CH 3 S O O NH Mycobacterium Exoenzyme Preclinical (in vitro) Beresford NJ, et al. 2009. J Antimicrob Chemother
3-((S)-2-(3-benzoyl-1-cyanoindolizin-5-yloxy)-4-methylpentanamido)-3-phenylpropanoic acid Depiction based on curated SMILES N O O N CH 3 H O N H H 3 C O OH Mycobacterium Exoenzyme Preclinical (in vitro) Weide T, et al. 2006. Bioorg Med Chem Lett
   


NOTE: for more interactive and statistic charts, please visit the JavaScript-rich interface of VFDB.



Page  1  2  3 



Back to top
2004-2025 NIPB, CAMS&PUMC